Skip to main content

AutoGenomics Pockets $12M in VC Cash; Will Expand Manufacturing, S&M

NEW YORK (GenomeWeb News) — AutoGenomics has hauled in $12 million through a Series C round of private-equity financing from non-institutional investors, the company said today.
 
President Fareed Kureshy said the company will use the cash to “extend our test application menu, expand manufacturing and increase our sales and marketing efforts” for its Infiniti film-based microarray system.
 
The assays are designed to help diagnose clotting disorder thrombophilia.
 
Kureshy said the company does not expect to require more funding for continued growth because its coagulation Factor II and V in vitro diagnostic tests and its analyzer were recently cleared by the US Food and Drug Administration.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.